Structural and Functional Brain Abnormalities in Mouse Models of Lafora Disease

Area of Science:

• Neuroscience
• Genetics
• Medical Imaging

Background:

• Lafora disease is a fatal genetic epilepsy caused by mutations in EPM2A (laforin) and EPM2B (malin) genes.
• Patient neuroimaging shows brain atrophy, altered glucose metabolism, and metabolite changes, primarily in the frontal cortex, basal ganglia, and cerebellum.
• Laforin- and malin-deficient mice mimic human Lafora disease features, including cognitive, motor, and epileptic deficits.

Purpose of the Study:

• To characterize the neuroimaging features of two Lafora disease mouse models.
• To compare imaging findings between Epm2a and Epmb mouse models and relate them to human patient data.
• To explore the utility of these models for understanding disease mechanisms and developing biomarkers.

Main Methods:

• Magnetic Resonance Imaging (MRI) for volumetric analysis of brain structures.
• Positron Emission Tomography (PET) to assess glucose uptake in specific brain regions.
• Magnetic Resonance Spectroscopy (MRS) to analyze brain metabolite concentrations.

Main Results:

• MRI revealed altered brain volumes in the cerebral cortex, hippocampus, basal ganglia, and cerebellum in both mouse models.
• PET scans showed abnormal glucose metabolism in the cerebral cortex, hippocampus, and cerebellum of Epm2a mice, but not Epm2b mice.
• MRS detected significant changes in brain metabolites, such as N-acetylaspartate (NAA), consistent with human patient findings.

Conclusions:

• Lafora disease mouse models exhibit distinct neuroimaging abnormalities mirroring human pathology.
• These models provide valuable insights into the pathophysiology of Lafora disease.
• Neuroimaging findings in these animal models may aid in developing diagnostic and therapeutic biomarkers for Lafora disease.